BRIEF published on 05/11/2026 at 11:15, 4 months 1 day ago Schloss Wachenheim AG : Résultats du troisième trimestre et prévisions actualisées Résultats Financiers Recommandation D'achat Schloss Wachenheim AG Impact Géopolitique Prévisions Du Marché
BRIEF published on 05/11/2026 at 11:15, 4 months 1 day ago Schloss Wachenheim AG: Third Quarter Results and Updated Forecast Financial Results Buy Recommendation Schloss Wachenheim AG Geopolitical Impact Market Forecast
PRESS RELEASE published on 05/11/2026 at 11:10, 4 months 1 day ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG (ISIN: DE0007229007) research with a Buy recommendation and reduced target price to EUR 18, reflecting weaker Q3 25/26 results First Berlin Equity Research Buy Recommendation Research Update Target Price Schloss Wachenheim AG
BRIEF published on 02/25/2026 at 13:51, 6 months 15 days ago Schloss Wachenheim AG : recommandation d'achat réaffirmée Résultats Financiers Recommandation D'achat Schloss Wachenheim AG Prix Cible Sentiment Des Consommateurs
BRIEF published on 02/25/2026 at 13:51, 6 months 15 days ago Schloss Wachenheim AG: Buy Recommendation Reaffirmed Financial Results Buy Recommendation Target Price Schloss Wachenheim AG Consumer Sentiment
PRESS RELEASE published on 02/25/2026 at 13:46, 6 months 15 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG with a BUY recommendation and revised target price of €19 based on Q2 25/26 results. EBIT rose 1.4% to €21.9m First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q2 25/26 Results €19 Target Price
BRIEF published on 11/10/2025 at 13:17, 10 months 2 days ago Schloss Wachenheim AG : Perspectives positives et objectif de cours relevé Schloss Wachenheim AG Résultats Du T1 2025/26 Relèvement De L'objectif De Prix Reprise Du Segment Français Impacts Sur Le Rendement Des Obligations
BRIEF published on 11/10/2025 at 13:17, 10 months 2 days ago Schloss Wachenheim AG: Positive Outlook with Increased Price Target Schloss Wachenheim AG Price Target Increase Q1 2025/26 Results France Segment Recovery Bond Yield Impacts
PRESS RELEASE published on 11/10/2025 at 13:12, 10 months 2 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research upgrades Schloss Wachenheim AG, recommends Buy with target price of €20 after strong Q1 25/26 results. Sales up 3.5% to €106.0m First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q1 25/26 Results €20 Target Price
BRIEF published on 09/30/2025 at 11:03, 11 months 12 days ago Schloss Wachenheim AG: Buy Rating Reiterated Despite Challenges Financial Results Buy Recommendation Sales Growth Schloss Wachenheim Market Forecast
Published on 09/12/2026 at 02:35, 1 day 6 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 10 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 12 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 16 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 15 hours 39 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 1 hour ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 11 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 11 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 13 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 13 hours ago Availability of the 2026 Interim Financial Report
